Anavex Life Sciences (AVXL) Return on Assets [ROA] (2017 - 2026)
Anavex Life Sciences (AVXL) posted Return on Assets [ROA] of -13.97% for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 33.67 percentage points from -47.65% a year earlier and up 15.51 percentage points from the prior quarter.
Powered by 
Analysis
Anavex Life Sciences (AVXL) Return on Assets [ROA] (2017 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Anavex Life Sciences' Return on Assets [ROA] came in at -42.95%, down 13.29 percentage points from FY2024.
- Annual Return on Assets [ROA] shows a five-year change of +44.84 percentage points (FY2020 to FY2025).
- In prior fiscal years, Anavex Life Sciences' Return on Assets [ROA] was -29.66% in FY2024 (+1.27 pp), -30.93% in FY2023 (-0.41 pp), -30.53% in FY2022 (+8.12 pp) and -38.65% in FY2021 (+49.14 pp).
- The fiscal Q3 2026 figure stands as the highest quarterly Return on Assets [ROA] in data going back to fiscal Q4 2017.
- On a year-over-year basis, Return on Assets [ROA] increased in two of the last eight quarters, with an average year-over-year change of -1.93 percentage points.
- The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was fiscal Q4 2021, with a gain of 56.29 percentage points; the weakest was fiscal Q4 2025, with a drop of 18.81 percentage points.
- According to Business Quant data, Return on Assets [ROA] for the three prior fiscal quarters was -29.48% (Q2 2026), -37.68% (Q1 2026) and -49.85% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.14% |
| 10 | Anavex Life Sciences | 168.71 Mn | -311.37 Mn | - | -13.97% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -13.97% |
| Mar 31, 2026 | -29.48% |
| Dec 31, 2025 | -37.68% |
| Sep 30, 2025 | -49.85% |
| Jun 30, 2025 | -47.65% |
| Mar 31, 2025 | -41.57% |
| Dec 31, 2024 | -37.02% |
| Sep 30, 2024 | -31.04% |
| Jun 30, 2024 | -28.99% |
| Mar 31, 2024 | -27.63% |
| Dec 31, 2023 | -28.46% |
| Sep 30, 2023 | -30.43% |
| Jun 30, 2023 | -32.54% |
| Mar 31, 2023 | -34.27% |
| Dec 31, 2022 | -33.27% |
| Sep 30, 2022 | -30.64% |
| Jun 30, 2022 | -28.32% |
| Mar 31, 2022 | -27.23% |
| Dec 31, 2021 | -25.69% |
| Sep 30, 2021 | -23.08% |
API Access
Anavex Life Sciences Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=AVXL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "AVXL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=AVXL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();